Aclaris Therapeutics Stock (NASDAQ: ACRS) stock price, news, charts, stock research, profile.
Open | $1.190 |
Close | - |
Volume / Avg. | 672.215K / 1.080M |
Day Range | 1.140 - 1.200 |
52 Wk Range | 0.590 - 11.120 |
Market Cap | $81.564M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 7.95% |
Days to Cover | 6.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aclaris Therapeutics (NASDAQ: ACRS) through any online brokerage.
Other companies in Aclaris Therapeutics’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Marinus Pharma (NASDAQ:MRNS), Anebulo Pharmaceuticals (NASDAQ:ANEB) and Milestone Pharmaceuticals (NASDAQ:MIST).
The latest price target for Aclaris Therapeutics (NASDAQ: ACRS) was reported by HC Wainwright & Co. on Monday, January 22, 2024. The analyst firm set a price target for 0.00 expecting ACRS to fall to within 12 months (a possible -100.00% downside). 16 analyst firms have reported ratings in the last year.
The stock price for Aclaris Therapeutics (NASDAQ: ACRS) is $1.1801 last updated Today at April 25, 2024 at 9:05 AM EDT.
There are no upcoming dividends for Aclaris Therapeutics.
Aclaris Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Aclaris Therapeutics.
Aclaris Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.